Ceradyne (CRDN) Shares Nosedive Following DA Davidson Downgrade
Tweet
Share
E-mailGet Alerts CRDN Hot Sheet
Price: $35.00 --0%
Rating Summary:
2 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
2 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
Shares of Ceradyne (NASDAQ: CRDN) are sinking midday Monday following a downgrade from DA Davidson's Avinash Kant. After trading in positive territory throughout the morning session, shares are now down 2.5 percent to $31.87.
The analyst now rates Ceradyne shares a Neutral, down from Buy previously. The firm's price target was lowered from $41 to $36.
For an analyst ratings summary and ratings history on Ceradyne click here. For more ratings news on Ceradyne click here.
The analyst now rates Ceradyne shares a Neutral, down from Buy previously. The firm's price target was lowered from $41 to $36.
For an analyst ratings summary and ratings history on Ceradyne click here. For more ratings news on Ceradyne click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oppenheimer Downgrades Legend Biotech Corp. (LEGN) to Perform, 'CEO/Partnership/Competition Overhangs to Cap Upside'
- Stephens Downgrades WSFS Financial (WSFS) to Equal Weight
- CFRA Downgrades 3M (MMM) to Buy
Create E-mail Alert Related Categories
DowngradesRelated Entities
D.A. DavidsonSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
